Lv54
1430 积分 2022-05-06 加入
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
1天前
待确认
Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer
6天前
已完结
Phase II Trial of XELOX as First-Line Treatment for Patients with Advanced Gastric Cancer
6天前
已完结
Pancreatic Cancer: A Review of Current Treatment and Novel Therapies
28天前
已完结
CD73 Is a Critical Immune Checkpoint in a Molecular Subtype of Pancreatic Cancer
1个月前
已完结
YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities
1个月前
已完结
P1.13A.01 DeLLphi-306 Trial: A Phase 3 Study of Tarlatamab after Concurrent Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer
1个月前
已关闭
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
1个月前
已完结
P1.13A.02 Tarlatamab Plus Durvalumab as First-Line Maintenance in Extensive-Stage Small Cell Lung Cancer: DeLLphi-305 Phase 3 Trial
1个月前
已关闭
Combination therapy with carboplatin and paclitaxel for small cell lung cancer
2个月前
已完结
皖公网安备34019202002308
